Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer

Acta Radiologica

Volumn 51, Issue 2, 2010, Pages 150-155

  Ozawa, Yoshiyuki ^a   Hara, Masaki ^a   Sakurai, Keita ^a   Nakagawa, Motoo ^a   Tamaki, Tsuneo ^b   Nishio, Masami ^b   Shibamoto, Yuta ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya PET Imaging Center   (Japan)

Author keywords

Lung cancer; Lymph node; N2; PET; Staging

Indexed keywords

COMPUTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FDG-PET; FLUORO D GLUCOSE; LUNG CANCER; LYMPH NODE; METASTATIC LESIONS; METASTATIC LYMPH NODES; NODAL STATUS; PET IMAGES;

BIOLOGICAL ORGANS; BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; GLUCOSE; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

AGED; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76749125921     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.3109/02841850903485763     Document Type: Article

References (27)

1. MacDonald SL, Hansell DM. Staging of non-small cell lung cancer: imaging of intrathoracic disease. Eur J Radiol 2003;45:18-30.
2. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of nonsmall cell lung cancer. Oncologist 2004;9:633-643
3. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 2003;76:861-866
4. Kernstine KH, Stanford W, Mullan BF, Rossi NP, Thompson BH, Bushnell DL, et al. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma. Ann Thorac Surg 1999;68:1022-1028
5. Birim O, Kappetein AP, Stijnen T, Bogers AJJC. Metaanalysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 2005;79:375-382
6. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastainal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-527
7. Halter G, Buck AK, Schirrmeister H, Aksoy E, Liewald F, Glatting G, et al. Lymph node staging in lung cancer using [18F]FDG-PET. Thorac Cardiovasc Surg 2004;52: 96-101.
8. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell-lung cancer: a metaanalysis. Ann Intern Med 2003;139:879-892
9. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschankelen JA, Nackaerts KL, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Chest 1997;112:1480-1486
10. Ebihara A, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Uno K, et al. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients. Jpn J Clin Oncol 2006;36:694-698
11. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 2005;47:235-242
12. Gonzalez-Stawinski GV, Lemarie A, Merchant F, O'Halloran E, Coleman RE, Harpole DH, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg 2003:126:1900-1905
13. Maeda J, Ohta M, Hirabayashi H, Matsuda H. False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer. Jpn J Thorac Cardiovasc Surg 2005;53:196-198
14. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 2004;127:1087-1092
15. Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, et al. The diagnostic accuracy of 18F-2-deoxyfluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Acta Radiol 2009;50:638-644
16. Libshtz HI, McKenna RJ Jr. Mediastinal lymph node size in lung cancer. Am J Roentogenol 1984;143:713-718
17. McLoud TC, Bourgounin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JO, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319-323
18. Arita T, Kuramitsu T, Kawamura M, Matsumoto T, Matsunaga N, Sugi K, et al. Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax 1995;50:1267-1269
19. Gross BH, Glazer GM, Orringer MB, Spizarny DL, Flint A. Bonchogenic carcinoma metastatic to normal-sized lymph nodes; frequency and signifi cance. Radiology 1988;166:71-74
20. Graeter TP, Hellwig D, Hoffmann K, Ukena D, Kirsch CM, Schafers HJ. Mediasinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann Thorac Surg 2003;75:231-236
21. Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, Pounds TR, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000;70:1154-1160
22. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dualmodality PET/CT in preoperative staging. Radiology 2003;229:526-533
23. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507 (Pubitemid 36706537)
24. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated Pet alone for staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017-1023
25. De Wever W, Ceyssens S, Mortelmans L, Stroobants S, Marchal G, Bogaert J, et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, Pet alone and visual correlation of PET and CT. Eur Radiol 2007;17:23-32. (Pubitemid 46063025)
26. Hunsaker AR, Munden RF, Pugatch RD, Mentzer SJ. Sarcoidlike reaction in patients with malignancy. Radiology 1996;200:255-261
27. Shiraki N, Hara M, Ogino H, Shibamoto Y, Iida A, Tamaki T, et al. False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET-radiologicalpathological correlation. Ann Nucl Med 2004;18:23-28